Cite
MLA Citation
Qing Huang et al.. “Healthcare resource utilization and costs associated with first-line ibrutinib compared to chemoimmunotherapy treatment among Medicare beneficiaries with chronic lymphocytic leukemia.” Current medical research and opinion, vol. 36, 2020, pp. 2009–2018. http://access.bl.uk/ark:/81055/vdc_100115130184.0x000050